Sio Gene Therapies Inc.
SIOX · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $46 | $50 | $55 | $64 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $4 | $4 | $8 |
| Total Curr. Assets | $47 | $54 | $59 | $72 |
| Property Plant & Equip (Net) | $0 | $0 | $3 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $3 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $47 | $54 | $62 | $75 |
| Liabilities | – | – | – | – |
| Payables | $0 | $2 | $2 | $4 |
| Short-Term Debt | $0 | $0 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $2 | $6 | $8 |
| Total Curr. Liab. | $2 | $5 | $9 | $13 |
| LT Debt | $0 | $0 | $2 | $2 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $2 | $2 | $2 |
| Other Liabilities | $0 | -$2 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $2 | $5 | $11 | $15 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$878 | -$874 | -$871 | -$863 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $923 | $923 | $923 | $923 |
| Total Equity | $45 | $49 | $52 | $60 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $47 | $54 | $62 | $75 |
| Net Debt | -$46 | -$50 | -$52 | -$61 |